This method proved successful for years, but high-strength concentrates would sometimes crystallise and clog the very small orifice through which the oil was to be delivered. Recognising the issue and the fact that most customers needed a higher dose to be delivered quickly, CannabiGold further developed its packaging to launch a side nozzle. This pump can deliver a higher dose of the oil (4 times what it used to) in one go and do it very easily under the tongue, without having to use a mirror to ensure one is getting the right number of drops. The easy dropper technology has boosted the good reputation of the already popular cylinder bottles because they’re easy and safe to use wherever you go with no leaking and a very convenient pocket size. Each of their 12g bottles now contains 100 pumps (full doses) of CBD, making it the easiest and most convenient system available, truly suitable for all use, including travel. Visit the CannabiGold collection.
CBD may offer an option for treating different types of chronic pain. A study from the European Journal of Pain showed, using an animal model, CBD applied on the skin could help lower pain and inflammation due to arthritis. Another study demonstrated the mechanism by which CBD inhibits inflammatory and neuropathic pain, two of the most difficult types of chronic pain to treat. More study in humans is needed in this area to substantiate the claims of CBD proponents about pain control.
CBD has been touted for a wide variety of health issues, but the strongest scientific evidence is for its effectiveness in treating some of the cruelest childhood epilepsy syndromes, such as Dravet syndrome and Lennox-Gastaut syndrome (LGS), which typically don’t respond to antiseizure medications. In numerous studies, CBD was able to reduce the number of seizures, and in some cases it was able to stop them altogether. Videos of the effects of CBD on these children and their seizures are readily available on the Internet for viewing, and they are quite striking. Recently the FDA approved the first ever cannabis-derived medicine for these conditions, Epidiolex, which contains CBD.
Dr. Cohen has found that chronic conditions including autoimmune diseases and pain syndromes can be helped with a 6-mg under-the-tongue tincture (the fastest delivery system) or a 25-mg capsule taken twice a day. Dosages for topical products like lotions are especially hard to determine—there’s no clarity on how much CBD gets into the system through the skin.
Currently, the only CBD product approved by the Food and Drug Administration is a prescription oil called Epidiolex. It's approved to treat two types of epilepsy. Aside from Epidiolex, state laws on the use of CBD vary. While CBD is being studied as a treatment for a wide range of conditions, including Parkinson's disease, schizophrenia, diabetes, multiple sclerosis and anxiety, research supporting the drug's benefits is still limited.